l-carnitine and diet | Linus Pauling Institute 3-MCC Management: Carnitine & Diet

The compounds regulatory status is uncertain, and any commercial use targeting human consumers risks regulatory action

[DOI] [PubMed] [Google Scholar] Riederer P., Sofic E., Rausch W.D., Schmidt B., Reynolds G.P., Jellinger K., Youdim M.B

doi: 10.1038/sj.bjp.0704216 99 CoppeyLJDavidsonEPRinehartTWGellettJSOltmanCLLundDDet al

Eur J Immunol 35:33433352 Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, Fritz B, Vobis D, Krammer PH, Suri-Payer E, Wildemann B (2007) Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis

View Abstract Vigabatrin for Epileptic Spasms and Tonic Seizures in Tuberous Sclerosis Complex

However, to date, no monoclonal therapy for FR has demonstrated a survival benefit over standard chemotherapy in a Phase 3 study